QuidelOrtho Corporation (QDEL)
Automate Your Wheel Strategy on QDEL
With Tiblio's Option Bot, you can configure your own wheel strategy including QDEL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol QDEL
- Rev/Share 39.9353
- Book/Share 29.9471
- PB 0.9343
- Debt/Equity 1.3965
- CurrentRatio 1.7798
- ROIC -0.1516
- MktCap 1900724489.0
- FreeCF/Share -0.6294
- PFCF -44.4095
- PE -1.6131
- Debt/Assets 0.5011
- DivYield 0
- ROE -0.4364
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | QDEL | Citigroup | Buy | Neutral | -- | $33 | Oct. 7, 2025 |
| Upgrade | QDEL | Jefferies | Hold | Buy | -- | $44 | May 8, 2025 |
| Upgrade | QDEL | Citigroup | Neutral | Buy | $44 | $50 | Dec. 11, 2024 |
| Initiation | QDEL | Jefferies | -- | Hold | -- | $43 | Dec. 10, 2024 |
| Resumed | QDEL | UBS | -- | Neutral | $42 | $50 | Sept. 19, 2024 |
| Upgrade | QDEL | Craig Hallum | Hold | Buy | $40 | $57 | Sept. 5, 2024 |
News
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Neutral
The medical device sector saw steady sales growth in the first quarter of 2025, supported by innovation in AI, wearables, and personalized care. However, earnings gains were more modest as global tariffs, inflationary costs, and supply chain disruptions continued to pressure margins.
Read More
4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
MedTech companies' quarterly results are likely to reflect base business recovery on a year-over-year basis. Let's see how HIMS, GMED, QDRL and HAE are poised ahead of their earnings release.
Read More
Why QuidelOrtho (QDEL) Could Beat Earnings Estimates Again
Published: April 24, 2025 by: Zacks Investment Research
Sentiment: Positive
QuidelOrtho (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
QuidelOrtho (QDEL) Surges 10.1%: Is This an Indication of Further Gains?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
QuidelOrtho (QDEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Read More
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Neutral
QDEL continues to witness growth on the back of its strong product portfolio.
Read More
QuidelOrtho Unveils Results Manager System to Streamline Testing
Published: March 14, 2025 by: Zacks Investment Research
Sentiment: Positive
QDEL introduces the Results Manager System, a powerful tool designed to streamline diagnostic data management, enhance efficiency, and improve patient care.
Read More
QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract
Published: February 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Despite solid performances by the Labs and Immunohematology units and China and Other regions, QDEL reports soft overall top-line results in fourth-quarter 2024.
Read More
QuidelOrtho Corporation (QDEL) Q4 2024 Earnings Call Transcript
Published: February 12, 2025 by: Seeking Alpha
Sentiment: Neutral
QuidelOrtho Corporation (NASDAQ:QDEL ) Q4 2024 Results Conference Call February 12, 2025 5:00 PM ET Company Participants Juliet Cunningham - Vice President, Investor Relations Brian Blaser - President and Chief Executive Officer Joe Busky - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Patrick Donnelly - Citi Bill Bonello - Craig-Hallum Lu Li - UBS Andrew Cooper - Raymond James Casey Woodring - JPMorgan Andrew Brackmann - William Blair Jose Ricardo - RBC Capital Markets Operator Welcome to the QuidelOrtho Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast. At this time, all participant …
Read More
About QuidelOrtho Corporation (QDEL)
- IPO Date 1991-02-01
- Website https://www.quidelortho.com
- Industry Medical - Instruments & Supplies
- CEO Brian J. Blaser
- Employees 6600